Johnson K P
Department of Neurology, University of Maryland Hospital, Baltimore 21201.
Neurology. 1988 Jul;38(7 Suppl 2):62-5.
While alpha and beta interferons are relatively nontoxic human gene products and have been used in the treatment of multiple sclerosis, the results of a pilot study in 18 patients treated with recombinant gamma interferon indicate that this form is unsuitable for therapy in MS.
虽然α干扰素和β干扰素是相对无毒的人类基因产物,已用于治疗多发性硬化症,但一项对18例接受重组γ干扰素治疗的患者进行的初步研究结果表明,这种形式不适用于多发性硬化症的治疗。